CANCERSUX Trademark

Trademark Overview


On Wednesday, July 9, 2025, a trademark application was filed for CANCERSUX with the United States Patent and Trademark Office. The USPTO has given the CANCERSUX trademark a serial number of 99275265. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, March 18, 2026. This trademark is owned by Amoura.Life LLC. The CANCERSUX trademark is filed in the Staple Food Products category with the following description:

Non-medicated lozenges
cancersux

General Information


Serial Number99275265
Word MarkCANCERSUX
Filing DateWednesday, July 9, 2025
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, March 18, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkCANCER SUCKS
Goods and ServicesNon-medicated lozenges

Classification Information


International Class030 - Coffee, tea, cocoa, sugar, rice, tapioca, sago, artificial coffee; flour and preparations made from cereals, bread, pastry and confectionery, ices; honey, treacle; yeast, baking powder; salt, mustard; vinegar, sauces (condiments); spices; ice.
US Class Codes046
Class Status Code6 - Active
Class Status DateWednesday, July 9, 2025
Primary Code030
First Use Anywhere DateTuesday, April 1, 2025
First Use In Commerce DateTuesday, April 1, 2025

Trademark Owner History


Party NameAmoura.Life LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSheridan, WY 82801
US

Trademark Events


Event DateEvent Description
Wednesday, July 9, 2025NEW APPLICATION ENTERED
Wednesday, July 9, 2025APPLICATION FILING RECEIPT MAILED
Friday, November 14, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 28, 2025ASSIGNED TO EXAMINER
Tuesday, December 2, 2025NON-FINAL ACTION WRITTEN
Tuesday, December 2, 2025NON-FINAL ACTION E-MAILED
Tuesday, December 2, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 18, 2026ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, March 18, 2026ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Related Keywords


cancersux lozenges medicated